Belgium - English - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

laboratoires juvise pharmaceuticals - metronidazole 125 mg; tetracycline hydrochloride 125 mg; bismuth subcitrate potassium 140 mg - capsule, hard - 140 mg - 125 mg - 125 mg - bismuth subcitrate potassium 140 mg; metronidazole 125 mg; tetracycline hydrochloride 125 mg - bismuth subcitrate, tetracycline and metronidazole

Israel - English - Ministry of Health

cts chemical industries ltd, israel - bismuth subsalicylate - suspension - bismuth subsalicylate 262 mg / 15 ml - bismuth subcitrate - bismuth subcitrate - relief of diarrhea, nausea, flatulence, convulsive stomach pains, uspet stomach. as a preventative treatment of traveler's diarrhea.

United States - English - NLM (National Library of Medicine)

h2-pharma, llc - bismuth subcitrate potassium (unii: r3o80h60kx) (bismuth cation - unii:zs9cd1i8ye), metronidazole (unii: 140qmo216e) (metronidazole - unii:140qmo216e), tetracycline hydrochloride (unii: p6r62377kv) (tetracycline - unii:f8vb5m810t) - pylera in combination with omeprazole are indicated for the treatment of patients with helicobacter pylori infection and duodenal ulcer disease (active or history of within the past 5 years) to eradicate h. pylori . the eradication of helicobacter pylori has been shown to reduce the risk of duodenal ulcer recurrence. to reduce the development of drug-resistant bacteria and maintain the effectiveness of pylera and other antibacterial drugs, pylera should be used to treat only indicated infections that are proven or strongly suspected to be caused by susceptible bacteria. when culture and susceptibility information are available, they should be considered in selecting or modifying antibacterial therapy. in the absence of such data, local epidemiology and susceptibility patterns may contribute to the empiric selection of therapy. do not administer methoxyflurane to patients taking pylera. the concurrent use of tetracycline hydrochloride, a component of pylera, with methoxyflurane has been reported to result in

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - bismuth subsalicylate - chewable tablets - bismuth subsalicylate 262 mg - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

Australia - English - APVMA (Australian Pesticides and Veterinary Medicines Authority)

ceva animal health pty ltd - bismuth subsalicylate - oral solution/suspension - bismuth subsalicylate mineral-bismuth active 17.5 mg/ml - alimentary system - dog | horse | bitch | castrate | colt | donkey | endurance horse | filly | foal | gelding | high performance horses | horses at - diarrhoea | absorptive | acute diarrhoea | acute intestinal catarrh | avian blackhead | bacterial enteritis | blackhead | chronic diarrhoea | coccidiosis | dietary factors | dietary upset | enteritis | feed conversion | flatulance | fluid loss | gastro-intestinal | gram negative bacteria | growth rate | k88+ serotypes of e.coli | nesting diarrhoea | non-specific irritants | poisoning | postweaning scours | prophylactic | scours | streptomycin sensitive bacteri | sulphadiazine sensitive bacter | sulphonamide sensitive bacteri | trichomoniasis | trimethoprim sensitive bacteri | white scours

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

a a h pharmaceuticals ltd - bismuth subnitrate; iodoform - cutaneous paste - 252mg/1gram ; 503mg/1gram

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - bismuth sub salicylate - suspension - bismuth sub salicylate 262.5 mg / 15 ml - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - bismuth subsalicylate - chewable tablets - bismuth subsalicylate 262 mg - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

Israel - English - Ministry of Health

perrigo israel agencies ltd, israel - bismuth subsalicylate - chewable tablets - bismuth subsalicylate 262 mg - bismuth subcitrate - bismuth subcitrate - for relief of diarrhea, nausea, flatulence, abdominal cramps, upset stomach and indigestion.

Canada - English - Health Canada

stanley pharmaceuticals, a division of vita health products inc. - bismuth subsalicylate - suspension - 17.6mg - bismuth subsalicylate 17.6mg - antacids and adsorbents